IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v598y2021i7881d10.1038_s41586-021-03893-6.html
   My bibliography  Save this article

Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Author

Listed:
  • Justina X. Caushi

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Jiajia Zhang

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Zhicheng Ji

    (Johns Hopkins University
    Duke University School of Medicine)

  • Ajay Vaghasia

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Boyang Zhang

    (Johns Hopkins University)

  • Emily Han-Chung Hsiue

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Ludwig Center and Howard Hughes Medical Institute at Johns Hopkins
    Johns Hopkins University)

  • Brian J. Mog

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Ludwig Center and Howard Hughes Medical Institute at Johns Hopkins
    Johns Hopkins University)

  • Wenpin Hou

    (Johns Hopkins University)

  • Sune Justesen

    (Immunitrack)

  • Richard Blosser

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Ada Tam

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Valsamo Anagnostou

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Tricia R. Cottrell

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Queens University)

  • Haidan Guo

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Hok Yee Chan

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Dipika Singh

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Sampriti Thapa

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Arbor G. Dykema

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Poromendro Burman

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Begum Choudhury

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Luis Aparicio

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Laurene S. Cheung

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Mara Lanis

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Zineb Belcaid

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Margueritta El Asmar

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Peter B. Illei

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Rulin Wang

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Jennifer Meyers

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Kornel Schuebel

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Anuj Gupta

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Alyza Skaist

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Sarah Wheelan

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Jarushka Naidoo

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Beaumont Hospital Dublin, RCSI University of Medicine and Health Science)

  • Kristen A. Marrone

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Malcolm Brock

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Jinny Ha

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Errol L. Bush

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Bernard J. Park

    (Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine)

  • Matthew Bott

    (Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine)

  • David R. Jones

    (Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine)

  • Joshua E. Reuss

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Georgetown Lombardi Comprehensive Cancer Center at Georgetown University)

  • Victor E. Velculescu

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Jamie E. Chaft

    (Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine)

  • Kenneth W. Kinzler

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Ludwig Center and Howard Hughes Medical Institute at Johns Hopkins
    Johns Hopkins University)

  • Shibin Zhou

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Ludwig Center and Howard Hughes Medical Institute at Johns Hopkins
    Johns Hopkins University)

  • Bert Vogelstein

    (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Ludwig Center and Howard Hughes Medical Institute at Johns Hopkins
    Johns Hopkins University)

  • Janis M. Taube

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Matthew D. Hellmann

    (Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine)

  • Julie R. Brahmer

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Taha Merghoub

    (Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine
    Immunology Program, Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center)

  • Patrick M. Forde

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Srinivasan Yegnasubramanian

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Hongkai Ji

    (Johns Hopkins University)

  • Drew M. Pardoll

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

  • Kellie N. Smith

    (Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins
    The Mark Center for Advanced Genomics and Imaging at Johns Hopkins
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

Abstract

No abstract is available for this item.

Suggested Citation

  • Justina X. Caushi & Jiajia Zhang & Zhicheng Ji & Ajay Vaghasia & Boyang Zhang & Emily Han-Chung Hsiue & Brian J. Mog & Wenpin Hou & Sune Justesen & Richard Blosser & Ada Tam & Valsamo Anagnostou & Tri, 2021. "Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers," Nature, Nature, vol. 598(7881), pages 1-1, October.
    • Handle: RePEc:nat:nature:v:598:y:2021:i:7881:d:10.1038_s41586-021-03893-6
    DOI: 10.1038/s41586-021-03893-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-021-03893-6
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-021-03893-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Celina Tretter & Niklas Andrade Krätzig & Matteo Pecoraro & Sebastian Lange & Philipp Seifert & Clara Frankenberg & Johannes Untch & Gabriela Zuleger & Mathias Wilhelm & Daniel P. Zolg & Florian S. Dr, 2023. "Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification," Nature Communications, Nature, vol. 14(1), pages 1-22, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:598:y:2021:i:7881:d:10.1038_s41586-021-03893-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.